A granulocyte inhibitory protein was isolated and characterized from uremic serum by using ion-exchange column chromatography, high-performance size-exclusion chromatography, and immunochemical procedures. The purification process concentrated the protein 240-fold and to a purity of >95%. An overall recovery of 45% was achieved; the purified protein had a specific activity of 104 units per mg of protein. The polypeptide had a molecular weight of -28,000 and an isoelectric point of 4.0-4.5. Amino acid sequencing of the NH2 terminus revealed a single sequence (Asp-Ile-Val-MetThr-Gln-Ser-Pro-Gly-Thr-Leu-Ser-Val-Ser-Pro-Gly-Glu-ArgAla-Thr) that proved to be nonhomologous with other serum proteins that appear during an inflammatory state. The polypeptide inhibited the uptake of deoxyglucose, chemotaxis, oxidative metabolism, and intracellular bacterial killing by polymorphonuclear leukocytes. A specific rabbit polyclonal antibody raised against the protein nullified these inhibitory changes. We contend that the protein is responsible for the leukocyte dysfunction that is commonly seen in patients with uremia.
The increased morbidity and mortality of patients with renal failure has been attributed to the dysfunction of polymorphonuclear (PMN) cells (1, 2). Since PMN cells are metabolically active, uremia could contribute to impaired function by means of disarrangements in their cellular biochemistry and biology. For example, PMN cells from individuals with renal failure demonstrated impaired glycolytic enzyme activity (3) , diminished intracellular ATP levels (4), attenuated chemotactic activity (5) , and a reduced oxidative metabolism, which leads to impaired bacteriocidal activity (6) . Conversely, hemodialysis improved the chemotactic response of PMN cells, which suggests the presence of an inhibitory factor(s) in uremic serum. In this context, factor(s) in the middle molecular weight range may be responsible for the dysfunction of the host's cellular immune system found in patients with renal failure (7) . We report here on the physicochemical and immunochemical characterization of a granulocyte inhibitory protein (GIP) that was isolated from the ultrafiltrate of a patient with chronic renal failure. The protein is capable of inhibiting the uptake of D-[3H]glucose in PMN cells; it reduces oxidative metabolism, inhibits chemotaxis, and diminishes intracellular killing of bacteria in PMN cells. In addition, a specific heterologous antibody prepared against the protein nullifies these changes.
MATERIALS AND METHODS
Protein Purification. Plasma ultrafiltrates were prepared from a patient with chronic renal failure by using a polysulfone filter (Fresenius, Oberursel, FRG) with a Mr cutoff of 30,000-50,000 in the Dialysis Unit of the Department of Medicine of the University of Freiburg, FRG. The filtrates were pooled and stored at -70TC. After thawing, the filtrate was concentrated 25-fold by means of an Amicon ultrafiltration cell with a PM 10 membrane, which has a Mr cutoff of -10,000. The concentrate was dialyzed overnight at 4TC in dialysis buffer [20 mM Tris HCI (pH 8.0)], after which it was chromatographed on an ion-exchange fast protein liquid chromatographic (FPLC) system (Pharmacia). The original concentrate was applied to a Mono Q 5/5 column equilibrated with the dialysis buffer. The material was eluted with a linear gradient of 0-1 M NaCl in 20 mM Tris-HCl (pH 8.0) [5% (wt/vol)] at a flow rate of 2 ml/min. Each fraction was tested for biological activity (for details, see below).
The fractions that contained biological activity were pooled and were concentrated by Iyophilization. The material was resuspended in water and chromatographed with a high-performance size-exclusion (HPSEC) column. The material was placed on a Zorbax GF 250 (Du Pont de Nemours, Homburg, FRG) column (9.4 mm i.d., 250 mm long) equilibrated with 0.2 M sodium phosphate buffer (pH 7.1) and eluted at a flow rate of 1 ml/min. The biologically active fractions were in the Mr range of 25,000-30,000. The active fractions were chromatographed a second time under the same conditions. Electrophoretic Analysis. The active fractions were analyzed with a gel electrophoresis system according to Laemmli et al. (8) with SDS/12.5% polyacrylamide gels under reducing and nonreducing conditions. Protein Concentration Determination. The concentration of the protein was measured by using the Lowry et al. method (9) .
Western Blot. The electrotransfer of the proteins from SDS/polyacrylamide gels to a nitrocellulose membrane was probed with a rabbit antibody conjugated to horseradish peroxidase (Bio-Rad).
Isoelectric Focusing. The analysis was performed by using a standard agarose gel isoelectric focusing method (10) employing pH 3-10 ampholytes (Pharmacia).
Amino Acid Sequencing. The NH2-terminal sequence determination was done by using the automated Edman degradation procedure. An Applied Biosystems model 470A gasphase sequencer was employed (11) . The respective phenylthiohydantoin derivatives were identified by an on-line reverse-phase HPLC (model 120A) that was fitted with a C18 (2 mm i.d., 25 cm long) column.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Antibody Production. Rabbits were injected subcutaneously at multiple sites with 170 ,ug of purified protein emulsified in Freund's complete adjuvant. Booster injections of 170 Ag of purified protein in incomplete adjuvant were administered on days 8, 15, and 22. The animals were sacrificed, and their serum was collected and stored at -700C. The IgG fraction was obtained by NH4SO4 precipitation and purified by ion-exchange column chromatography on DEAE-Sephacel (Pharmacia) by using 17 mM sodium phosphate (pH 6.8).
ELISA Assay. The assay was used to detect and titer the specific polyclonal antibody. Microtiter plates were coated with the purified GIP antigen to which various concentrations of the antibody were added. The antibody was detected with a goat anti-rabbit peroxidase-conjugated antibody and visualized with 1,2-phenylenediamine as the substrate.
PMN Cell Function Tests. The PMN cells were isolated from venous blood of normal donors according to Metcalf et al. (12) . Their viability was determined by the trypan blue exclusion test, and it was found to be 96%. Intracellular killing activity of Staphylococcal aureus was assessed according to Metcalf et al. (12) . The chemotaxis assay was performed by using the agarose procedure (13) . A chemiluminescence assay was used to measure the oxidative respiratory burst potential of the PMN cells, and it was performed according to Metcalf et al. (12) . D-[3Hjglucose uptake was assessed according to McCall et al. (14) .
GIP Activity. Specific GIP activity was determined in terms of its ability to inhibit the N-formylmethionylleucylphenyl- Further enrichment of GIP activity was achieved by HPSEC. Pooled fractions from eight gel-filtration experiments (16 mg of protein) were used (Fig. 2) . The major activity (500 Ag of protein), which eluted in fractions 20 and 21 at a retention time of 20.49 min, inhibited the uptake of D-[3H]glucose into PMN cells. The biological activity of the other fractions was insignificant. The fraction containing GIP activity was once again extensively dialyzed and then concentrated by vacuum dialysis; its volume was reduced to 1.9 ml, and it was stored at -70°C.
The purity of the concentrated GIP was determined by gel electrophoresis under reducing and nonreducing conditions. The SDS/PAGE data for the initial material (Fig. 3a, lane 2) and the GIP active fraction after FPLC (Fig. 3a, lane 3) and HPSEC (Fig. 3a, lane 4) A Western blot of the gel probes that us specific for GIP is illustrated in Fig. 3b. immunoreactive band is present in the same I Lanes 3 and 4 in Fig. 3b (reduced protein) co GIP peak in fractions 15, 16, and 17 shown fractions 20 and 21 illustrated in Fig. 2 . The ir suggest that the corresponding peaks were GIP with a Mr of 28,000. The isoelectric pc between 4.0 and 4.5. A second band, mu stained, was also noted.
The amino acid sequence analysis of th revealed the following NH2-terminal sequenc Met-Thr-Gln-Ser-Pro-Gly-Thr-Leu-Ser-Va Glu-Arg-Ala-Thr.
Yields of GIP. The protein content of c preparation (9500 ml) was 272 mg of protein; i by the Lowry procedure (9). The ,ug/ml (n = 5); and the IC50 for inhibiting the intracellular killing of S. aureus 502 by the PMN cells was 7.9 ± 1.7 ,tg/ml (n = 6). The neutralizing effect of anti-GIP antibody is depicted in Fig. 4 . In addition to these inhibitory changes, GIP blocks the activity of other metabolic enzymes of PMN cells: phosphorylase, cytochrome c, and glycogen synthetase. Moreover, the release of elastase, lactoferrin, and myeloperoxidase was also inhibited by GIP. The results of these inhibitory effects by GIP will be described elsewhere. Boiling the GIP for 20 min destroyed its activity. When PMN cells were exposed to high concentrations (up to 500 Ag/ml) of GIP, their viability was unaffected, although they were biologically dysfunctional; following the removal ofthe factor by washing, normal The observed retention times on HPSEC for GIP purification location as GIP.
from various ultrafiltrate preparations were consistent, rrespond to the which allowed a reliable preparative isolation of the protein.
in Fig. 1 One unit corresponds to with GIP plus anti-GIP antibody for 30 min at 37C after which 2 x 107 S. aureus 502 were added. At various incubation times, the cells were centrifuged, resuspended in the presence of lysostaphin (10 units/ml) for 15 min to destroy extracellular bacteria. The number of bacteria phagocytosed by the PMN cells was then assessed. As a control, the polyclonal antibodies obtained from rabbits did not affect the biological responsiveness of the PMN cells.
biological conditions. However, one has to consider that the following events may play an important role in the production of GIP: the direct immunosuppressive effects of uremic toxins, the indirect effects of metabolic anomalies in chronic renal failure, and the contact effect of the dialysis membrane on blood constituents (i.e., cells and complement factors). Furthermore, since most of the patients are suffering from severe infections, there is a possibility that GIP may be derived from one of the infecting microorganisms. The possibility of a middle-range molecular weight protein present in uremic serum that leads to the impairment of leukocyte function has been described previously (7) . This goes along with recent observations in which the pathogenesis of infection in uremic individuals favors a direct immunosuppressive action of the host's cellular defense mechanisms (2). Thus, GIP blocks fundamental PMN cell function, which is relevant for controlling biological homeostasis. As a consequence, the following has to be taken into consideration: (i) GIP is restricted to the uremic syndrome; thus, its early detection may be beneficial for the prognosis of the host, and an appropriate intervention (i.e., immunization) could then be considered as an appropriate therapeutic strategy. (ii) GIP is not restricted to uremic individuals, and one has to consider the role of the factor in the pathogenesis of various clinical disorders associated with an increased susceptibility to infection (seen in immunocompromised individuals). (iii) The IC50 of GIP required to inhibit both the biochemical and functional changes is in the nanomolar range; therefore, the efficacy of the protein is well within the range of physiological effector substances (i.e., lymphokines and cytokines). (iv) The biological activity of PMN cells can be restored after the removal of GIP, and it is therefore possible that the function of the protein is of physiological relevance. For example, it may be capable of counterbalancing the overriding stimulatory effects of inflammatory and immunological stimuli on the PMN cells. In summary, GIP is a protein with multiple biological implications. How 
